Hantavirus Outbreak Expands to Multiple Countries as US Cruise Passenger Exits Isolation

On April 1, 2026, the MV Hondius — a 170-passenger expedition vessel operated by Dutch company Oceanwide Expeditions — departed Ushuaia, Argentina, bound for Antarctica, South Georgia Island, and a string of remote Atlantic outposts [1]. Five days later, a 70-year-old Dutch man developed fever, headache, and diarrhea. By April 11, he was dead of respiratory distress [2]. His wife fell ill during the return voyage and died shortly after [3]. A third passenger, from South Africa, also died [1].

What began as an isolated medical emergency at sea has become a multi-country public health event involving at least 11 reported cases of Andes hantavirus — nine confirmed, two probable — across eight countries, with a case fatality ratio of 27% [4]. Passengers are now quarantined or monitored in biocontainment units from Nebraska to the Netherlands, and a trail of unanswered questions stretches from the ports of Patagonia to the corridors of the WHO.

The Outbreak by the Numbers

As of May 13, 2026, the WHO has reported 11 total cases linked to the MV Hondius, including three deaths [4]. Eight cases have been laboratory-confirmed for Andes virus (ANDV) infection, two are classified as probable, and one remains inconclusive [4]. The affected passengers are hospitalized or under monitoring in the Netherlands, France, Spain, Germany, South Africa, Saint Helena, Switzerland, and the United States [1][5].

Source: WHO/ECDC

Data as of May 13, 2026CSV

The ship carried 86 passengers and 61 crew from 23 nationalities [6]. Passengers came predominantly from Spain, France, the United Kingdom, and the United States, while the crew was largely Filipino — 38 Philippine nationals serving as hotel, deck, and engine staff [7]. Oceanwide Expeditions has stated that 122 people (87 guests and 35 crew) were repatriated to their home countries and the Netherlands, while 27 crew remained aboard as the ship sailed to Rotterdam [7].

The 27% case fatality ratio observed so far sits below the 35% historical average for Hantavirus Pulmonary Syndrome (HPS) in the United States [8], though the number may shift: the Andes virus has an incubation period of up to 42 days, meaning additional cases could emerge through mid-June [6].

Tracing the Source: Rodents on Land, Not at Sea

The central epidemiological question — where did the virus come from? — remains under active investigation. The WHO's working hypothesis is that the index case acquired the infection on land before boarding the ship [4]. Argentine and Chilean authorities are collaborating on the inquiry [4].

The Dutch couple believed to be the index cases had completed a four-month road trip through Chile, Uruguay, and Argentina, including a bird-watching excursion in the Ushuaia area, where the long-tailed pygmy rice rat (Oligoryzomys longicaudatus), the primary reservoir for Andes virus, is endemic [9]. This land-based exposure timeline aligns with the first patient's symptom onset on April 6, just five days after embarkation [2].

No reports have indicated that rodent vectors were found in cabins or cargo holds aboard the Hondius. The Argentine investigation has focused on pre-boarding exposure rather than onboard infestation [9]. ABC News reported that medical experts have largely ruled out the theory of a single onboard rodent source, pointing instead to the index case's extensive travel through endemic regions [10].

Person-to-Person Transmission: The Andes Virus Exception

The Andes virus occupies a unique position among hantaviruses: it is the only strain known to transmit between humans [6]. Most hantaviruses — including the Sin Nombre virus responsible for the vast majority of U.S. HPS cases — spread exclusively through inhalation of aerosolized rodent droppings, urine, or saliva. Person-to-person transmission does not occur with these strains [11].

Andes virus is different, but transmission between humans remains uncommon. An estimated 2% to 5% of all Andes virus cases globally result from person-to-person spread, typically through close, sustained contact such as household caregiving without protective equipment [11]. The BMJ published an editorial arguing that the Hondius outbreak "should reset WHO's default approach to airborne risk," noting that the ship's enclosed environment — shared dining rooms, narrow corridors, limited ventilation — created conditions favorable for respiratory transmission [12].

Whether the secondary cases aboard the Hondius resulted from person-to-person transmission or from shared land-based rodent exposures at port destinations remains unresolved. Multiple passengers visited the same sites in the Ushuaia region, and epidemiologists have not ruled out independent exposures at shared locations [10].

Quarantine Across Three Continents

The international response has unfolded across a patchwork of national protocols. The Hondius docked in Tenerife, in Spain's Canary Islands, on May 10, where passengers disembarked and were triaged for evacuation flights [13]. Repatriation flights carried passengers to six European countries and Canada [1].

In France, repatriated passengers were placed in biocontainment units, and by May 13, a French patient was reported critically ill [14]. In the Netherlands, returning passengers were asked to self-isolate at home for six weeks, though some were placed in biocontainment for a minimum of two weeks [1]. In Canada, four passengers from British Columbia were isolating for a minimum of 21 days [15].

In the United States, 18 passengers — 17 Americans and one British dual national residing in the U.S. — arrived at specialized facilities on May 11 [16]. Sixteen were transported to the University of Nebraska Medical Center (UNMC) in Omaha, which operates one of the few federal biocontainment units in the country [17]. One of the Nebraska patients tested "mildly" positive for Andes virus [16]. Two passengers were sent to Emory University's biocontainment unit in Atlanta, one of whom was symptomatic but subsequently tested negative [18].

A Minnesota resident who was potentially exposed to the virus is being monitored by state health officials [19]. Separately, a possible hantavirus case under investigation in Illinois was reported as not linked to the MV Hondius [20].

Cross-Border Communication: Who Knew What, When?

The formal notification chain began on May 2, when the United Kingdom notified the WHO under International Health Regulations (IHR) after passengers aboard the vessel developed severe respiratory illness [21]. The WHO then coordinated information sharing with national focal points through IHR channels [21].

But the CDC has faced criticism for the pace of its response. Public health experts told media outlets that the agency was "missing in action" in the early days of the outbreak, with limited public communication until May 8 — nearly a week after the WHO was notified [21]. On May 9, CDC officials declined to directly answer whether American passengers evacuated from the ship could voluntarily leave quarantine [21]. The CDC sent a team to meet the ship in the Canary Islands on May 7 [6] and subsequently issued a Health Alert Network (HAN) notice on May 11 [22].

The Minnesota case raises additional questions. MPR News reported on May 12 that the state was monitoring a resident with potential hantavirus exposure linked to the outbreak [19]. Whether this individual was identified through formal CDC channels or through the passenger's own reporting is not clear from available sources.

A Disease With No Approved Treatment

There is no FDA-approved vaccine or antiviral treatment for hantavirus pulmonary syndrome [23]. Treatment remains supportive: oxygen therapy, mechanical ventilation, and in severe cases, extracorporeal membrane oxygenation (ECMO) [6]. This places hantavirus in a category of pathogens where mortality depends almost entirely on the speed and quality of intensive care, not on pharmaceutical intervention.

The thin therapeutic pipeline reflects decades of underinvestment. NBC News reported that scientists are working on a hantavirus vaccine, but it is "likely years away" [23]. Dr. Jay Hooper and colleagues have developed a DNA vaccine candidate for the Andes virus that showed promise in a Phase 1 trial, with over 80% of participants producing neutralizing antibodies, but no candidate has advanced to Phase 3 [23]. One leading candidate from EnsiliTech has not yet entered human testing and could take three to four more years before early-stage clinical trials begin [23].

Scientific American reported that hantavirus treatments "are coming, but funding is holding them back" [24]. The core problem is economic: with only an estimated 10,000 infections globally per year and as few as 20 to 40 U.S. cases annually, pharmaceutical companies have had little financial incentive to invest [23]. Since surveillance began in 1993, only 890 cases of hantavirus disease have been reported in the United States, 859 of which developed HPS [8].

Source: CDC

Data as of Dec 31, 2023CSV

BARDA, the federal agency responsible for medical countermeasure development, lists hantavirus among its priorities but has not publicly disclosed dedicated funding levels for hantavirus-specific therapeutics [25]. Drug Discovery News reported that the outbreak has "put a spotlight on antiviral drug discovery gaps" — a pattern familiar from other neglected diseases where sporadic outbreaks fail to sustain the investment needed for clinical trials [26].

Legal Liability: An Uphill Climb for Passengers

Passengers or their families may pursue negligence claims against Oceanwide Expeditions, but legal experts have described the path as difficult. Under maritime law, cruise operators are required to exercise "reasonable care under the circumstances," including isolating sick passengers, maintaining sanitation, and communicating health risks [27].

However, proving negligence in a viral outbreak case requires demonstrating that the cruise line failed to take reasonable precautions and that this failure contributed to illness [27]. If the index case contracted the virus on land before boarding — as the current evidence suggests — establishing that Oceanwide's shipboard protocols caused the infections becomes significantly harder [9].

Oceanwide's terms and conditions stipulate that any lawsuit must be filed in the Netherlands [9]. Under Dutch law, proving gross negligence or recklessness requires evidence that the company knew something was dangerous and proceeded anyway — for example, ignoring warnings from health authorities or failing to follow basic infection-control protocols [9]. As of May 13, no lawsuits have been publicly filed [9].

Moneywise reported that "maritime law means the cruise line probably owes nothing," noting that for non-shipping incidents like viral outbreaks, passenger compensation is far from guaranteed [28]. The precedent set by COVID-19 cruise outbreaks in 2020 is instructive but not directly analogous: in those cases, cruise lines were accused of continuing to operate despite known pandemic risk, a more straightforward negligence argument than the one available in a hantavirus case where the virus was carried aboard unknowingly by a passenger [28].

Who Is Most at Risk?

The MV Hondius passenger demographic skews older and wealthier — typical of expedition cruising. The index case was 70 years old [2]. Age is a significant risk factor for hantavirus severity: the historical U.S. case fatality rate of 35% masks variation by age group, with older patients and those with underlying cardiovascular or pulmonary conditions facing higher mortality [8].

Crew members, particularly the 38 Filipino nationals working in hotel and deck services, represent a distinct risk population. These workers had sustained close contact with passengers in enclosed ship environments — precisely the conditions associated with Andes virus person-to-person transmission [7]. The ECDC's rapid scientific advice specifically addressed the management of crew as a high-exposure group [29].

Dockworkers and port personnel at stops including Ushuaia, Cape Verde, and Tenerife were not identified as exposed populations in available reports, though the ship made port calls at several locations during the period when infected passengers were symptomatic [1].

The Broader Context: Expedition Cruising Under Scrutiny

The Hondius outbreak is the first documented hantavirus cluster linked to a cruise ship [2]. It arrives at a moment when expedition cruising — small-ship voyages to remote, ecologically sensitive destinations — is one of the fastest-growing segments of the cruise industry. These voyages routinely visit regions where zoonotic diseases are endemic, from Patagonian rodent habitats to tropical ports with dengue and chikungunya risk.

The Traveler reported that the outbreak "puts expedition ship safety under scrutiny," noting that smaller expedition vessels often lack the onboard medical infrastructure of larger cruise ships [30]. The Hondius had no ICU capability; the first patient who died received care from the ship's medical staff but could not be evacuated in time due to the vessel's remote location in the South Atlantic [2].

WHO Director-General Tedros Adhanom Ghebreyesus traveled to Tenerife for the disembarkation and stated that there is "no sign of a larger outbreak" [31]. The ECDC's assessment, published May 13, characterized the risk to the general European population as "very low" but emphasized that repatriated passengers require monitoring for the full 42-day incubation period [29].

The questions that remain unanswered — the exact source of the initial exposure, the extent of person-to-person transmission aboard the ship, the adequacy of cross-border notification timelines — will shape not only the regulatory response to this outbreak but the standards applied to an industry that sends tens of thousands of passengers annually to the edges of the inhabited world.